Lexaria Bioscience（LEXX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他90.59%
机构投资者6.39%
个人与内部人士1.67%
私营企业1.36%

主要股东

主要股东最新
股东
Invenomic Capital Management LP	1.78%	2.95 万	0.11%	-1,908.00	2026/03/31
Vanguard Capital Management, LLC	1.58%	2.62 万	0.31%	+5,076.00	2026/06/30
CAB Financial Services Ltd.	1.14%	1.88 万	<0.01%	+0	2025/12/01
Christopher BunkaChairman of the Board	1.10%	1.82 万	<0.01%	+0	2026/03/17
Geode Capital Management, LLC	1.01%	1.67 万	0.17%	-2,916.00	2026/06/30
The Toronto-Dominion Bank	0.56%	9,333.00	<0.01%	+0	2026/03/31
Richard ChristopherCEO & Director	0.26%	4,333.00	<0.01%	+0	2025/12/01
Docherty Management Ltd.	0.22%	3,605.00	<0.01%	+0	2025/12/01
UBS Asset Management AG	0.19%	3,131.00	0.02%	-382.00	2026/06/30
Northern Trust Global Investments	0.16%	2,655.00	0.09%	+1,430.00	2026/06/30
State Street Investment Management	0.16%	2,620.00	<0.01%	+0	2026/06/30
BlackRock, Inc.	0.11%	1,829.00	<0.01%	+0	2026/06/30
Sterne Agee Asset Management, Inc.	0.10%	1,714.00	--	+1,714.00	2026/06/30
XTX Markets Limited	0.10%	1,671.00	--	+1,671.00	2026/03/31
Krilogy Financial LLC	0.10%	1,610.00	0.02%	+300.00	2026/06/30
Virtu Financial, Inc.	0.08%	1,260.00	0.08%	+1,260.00	2026/06/30
Hudson River Trading LLC	0.07%	1,231.00	--	+1,231.00	2026/03/31
William McKechnieIndependent Director	0.07%	1,213.00	<0.01%	+0	2025/12/01
Renaissance Technologies LLC	0.07%	1,100.00	<0.01%	+14.00	2026/06/30
Vontobel Asset Management, Inc.	0.06%	1,012.00	0.03%	-521.00	2026/06/30